Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

The success of clinical trials of selective B‐cell depletion in patients with relapsing multiple
sclerosis (MS) and primary progressive MS has led to a conceptual shift in the …

Background and Objective There are few studies comparing lesion evolution across different
CNS demyelinating diseases, yet knowledge of this may be important for diagnosis and …

Objective To elucidate the differences in the source and in the level of intrathecal synthesis
between anti–aquaporin-4 antibodies (AQP4-IgG) and anti-myelin oligodendrocyte …

Antibody-mediated disorders of the central nervous system (CNS) are increasingly
recognized as neurologic disorders that can be severe and even life-threatening but with the …

In the past few years, acquired demyelinating syndromes of the central nervous system
associated with antibodies against myelin oligodendrocyte glycoprotein (MOG) have …

Spinal cord involvement is a hallmark feature of multiple sclerosis, neuromyelitis optica with
AQP4 antibodies and MOG-antibody disease. In this cross-sectional study we use …

Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) is a spectrum of diseases,
including optic neuritis, transverse myelitis, acute disseminated encephalomyelitis, and …

Inflammatory myelopathies can manifest with a combination of motor, sensory and
autonomic dysfunction of variable severity. Depending on the underlying etiology, the …